Education
About Us
Working with TipRanks
Follow Us
Vikas Sinha Insider Profile
4 Followers
Vikas Sinha, EVP & CFO at Alexion Pharmaceuticals, holds 774.12K shares in AlloVir (Ticker: ALVR), holds 74.44K shares in Verona Pharma (Ticker: VRNA), holds 171.86K shares in Alexion Pharmaceuticals (Ticker: ALXN). Most recently, Vikas Sinha Sold ― shares of AlloVir on Feb 24, 2025 for an estimated value of 3.05K.
Profitable Transactions
36 out of 41 Profitable Transactions
Average Return
+31.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Vikas Sinha holds in companies
Most Profitable Insider Trade
The most profitable trade made by Vikas Sinha
Vikas Sinha's Trading History
Alexion Pharmaceuticals
Aug 10, 2016
―
Informative Sell
37.99K
$31.36M
AlloVir
Feb 24, 2025
President, CFO and CEO, Director, Ten Percent Owner
Informative Sell
3.05K
$7.64M
Verona Pharma
May 05, 2021
Director
Uninformative Sell
8.31K
$4.81M
List of latest transactions for each holding click on a transaction to see Vikas Sinha's performance on stock
You May Also Like
Vikas Sinha insider profile FAQ
What is the percentage of profitable transactions made by Vikas Sinha?
The percentage of profitable transactions made by Vikas Sinha is 88%.
What is the average return per transaction made by Vikas Sinha?
The average return per transaction made by Vikas Sinha is 31.20%.
What stocks does Vikas Sinha hold?
Vikas Sinha holds: ALXN, ALVR, VRNA stocks.
What was Vikas Sinha’s latest transaction?
Vikas Sinha latest transaction was an Informative Sell of $3.05K.
What was Vikas Sinha's most profitable transaction?
Vikas Sinha’s most profitable transaction was an Informative Sell of ALVR stock on October 24, 2022. The return on the trade was 80.70%.
What is Vikas Sinha's role in Alexion Pharmaceuticals?
Vikas Sinha's role in Alexion Pharmaceuticals is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.